Atrial Fibrillation and Anticoagulation: One Size Fits All?

In their article, Shah and colleagues demonstrate vulnerability in the assumption of a universal net benefit of anticoagulation for a specific CHA₂DS₂-VASc score by applying analytic models of the score to 4 cohorts. The editorialists discuss the findings and their implications.

https://ift.tt/2pz7flW